ACTIVE

Dr. Dedovic Amintas

Financial year 2024 · Closed on 31/12/2024

Net result109,7 k €+17,5 %over 1 year
Gross margin175,3 k €+10,3 %over 1 year
Equity87,2 k €-63,7 %over 1 year

Identity

Source · BCE/KBO

Dr. Dedovic Amintas is a Private limited company incorporated in 2019. Its main activity is: Specialist medical practice activities. Its registered office is in Roeselare.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0723.892.588
Incorporation
01/04/2019
Legal form
Private limited company
Registered office
Rumbeeksesteenweg 459
8800 Roeselare · FlandreSee on map
Contributed capital
18 600,00 €
Latest accounts
31/12/2024
Signals
ProfitableLow riskPositive cashflowPositive EBITDA

Financials

Source · NBB, 5 filings

Trend over 4 financial years

2024202320222021
Income statement
Gross margin175,3 k €158,9 k €179 k €158,4 k €
EBITDA170,4 k €154,1 k €173,4 k €151,9 k €
Operating result140,3 k €123,8 k €148,5 k €127,9 k €
Net result109,7 k €93,4 k €116,8 k €97 k €
Balance sheet
Equity87,2 k €240,5 k €247,1 k €130,3 k €
Total assets443,8 k €563,7 k €665,5 k €459,6 k €
Cash145,9 k €122,5 k €235,6 k €89,5 k €
Debts356,6 k €323,2 k €418,2 k €329,2 k €

Valuation

Indicative valuation

As an indication, this company is worth

between 500 k€ and 1 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2024

1 active · 1 ended

Active mandates

Amintas Dedovic

Bestuurder · since 29 mars 2019

Active

Ended mandates

Amintas Dedovic

Director · since 29 mars 2019

Ended

Full financial information

Source · NBB
20242023202220212020
Type of accountMicro modelMicro modelMicro modelMicro modelMicro model
Start of the financial year01/01/202401/01/202301/01/202201/01/202129/03/2019
Closing of the financial year31/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months22 months
Filing date23/07/202504/07/202431/07/202329/09/202229/07/2021
General meeting28/06/202529/06/202415/07/202325/06/202226/06/2021
Currency of the financial yearEUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 5 filings
ModelClosingGeneral meetingFiledLanguageDocument
Micro model31/12/202428/06/202523/07/2025DutchPDF
Micro model31/12/202329/06/202404/07/2024DutchPDF
Micro model31/12/202215/07/202331/07/2023DutchPDF
Micro model31/12/202125/06/202229/09/2022DutchPDF
Micro model31/12/202026/06/202129/07/2021DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 k€ and 1 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2024

1 active · 1 ended

Active mandates

Amintas Dedovic

Bestuurder · since 29 mars 2019

Active

Ended mandates

Amintas Dedovic

Director · since 29 mars 2019

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates28/09/2023
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - WIJZIGING RECHTSVORM - DIVERSEN - ONTSLAGEN - BENOEMINGEN
    PDF
  • Other03/04/2019
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2024
    Annual accounts 2024109,7 k €↑
  2. 2023
    Annual accounts 202393,4 k €↓
  3. 2022
    Annual accounts 2022116,8 k €↑
  4. 2021
    Annual accounts 202197 k €
  5. 01/04/2019
    IncorporationPrivate limited company